Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,914.00
Bid: 10,918.00
Ask: 10,922.00
Change: 52.00 (0.48%)
Spread: 4.00 (0.037%)
Open: 10,946.00
High: 11,018.00
Low: 10,858.00
Prev. Close: 10,862.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: boohoo Launches UK Supply Chain Review

Wed, 08th Jul 2020 07:43

(Alliance News) - Stock in London are set to open in negative territory on Wednesday, following a lower close in the US overnight, with traders focusing on UK Chancellor Rishi Sunak speech scheduled later in the day.

On the corporate front, transport company FirstGroup reported a widened loss in its most recently ended financial year amid additional charges, while clothing retailer boohoo launched an independent review of its UK supply chain.

IG says futures indicate the FTSE 100 index of large-caps to open 44.60 points lower at 6,145.30 on Wednesday. The blue-chip index closed down 96.04 points, or 1.5%, at 6,189.90 on Tuesday.

"Stock markets in Europe lost ground yesterday as traders were quick to book their profits from the impressive gains that were racked up on Monday," said CMC Markets UK analyst David Madden. "Yesterday's move was more about a correction rather than a sharp change in outlook."

The economic events calendar on Wednesday has summer economic update from UK Chancellor Rishi Sunak at 1230 BST and US consumer credit at 2000 BST.

"Rishi Sunak, the chancellor of the Exchequer, will be in focus today as he is tipped to unveil various schemes that are aimed at aiding the economy. Some of the programmes have already been announced," added Madden.

Homeowners will receive GBP2 billion in financial incentives to insulate their homes as part of an economic recovery scheme set to be announced by the Chancellor.

The funding is part of an expected GBP3 billion green package Rishi Sunak will unveil on Wednesday to create jobs, upgrade buildings and protect the environment as part of efforts to rebuild the economy after Covid-19.

The scheme will also include a GBP1 billion programme to transform schools, hospitals and other public buildings so they are greener and more energy efficient.

In early company news, drugmaker AstraZeneca said Lynparza has been approved in the EU for patients with germline BRCA-mutated metastatic pancreatic cancer.

The approval was based on results from the phase III Polo trial.

"Today's approval opens the door to a new era of biomarker-led care for patients with metastatic pancreatic cancer in the EU, which has the highest incidence of any region globally," said Hedy Kindler, co-principal investigator of the POLO trial.

Real estate investment trust SEGRO updated the market on rental collections from its UK portfolio associated with the UK quarterly payment date of June 24, saying that 93% of the GBP37 million of rent due was received.

The company noted that GBP9 million of rent ordinarily due on the UK quarterly payment date has been re-profiled, mostly to be paid in the second half of 2020.

Turning to FTSE 250-listed, Aberdeen, Scotland-based transport company FirstGroup reported widened a pretax loss of GBP299.6 million for the year to the end of March compared with GBP97.9 million loss a year ago.

FirstGroup explained that the loss reflects charges relating to the North American self-insurance provision, Greyhound impairment charges, restructuring and reorganisation costs and coronavirus-related charges.

Trading trends prior to the pandemic were broadly similar throughout the year, the company noted, with industry cost pressures offset by revenue growth in First Student, First Transit and First Bus and management actions.

Annual revenue, meanwhile, grew to GBP7.75 billion from GBP7.13 billion year-on-year.

FirstGroup is not proposing to pay a dividend for financial 2020, but said it will continue to review the appropriate timing for restarting dividend payments.

Property investment company CLS Holdings said vacancy rates have increased from the end of December 2019 levels due to refurbishments, acquired vacancy in the UK and some recent lease expiries across the portfolio.

Since April 8, there have been 25 deals securing GBP3.2 million of annual rent, CLS said.

The company said its balance sheet remains well-capitalised and robust. As at the end of June, CLS had cash of over GBP190 million, with a further GBP50 million in undrawn facilities.

Lancashire, England-based Victrex said it had a solid start but weaker end to its third quarter as Covid-19 headwinds hurt performance.

The polymer solutions provider reported a 12% drop in sales volume for the three months to the end of June to 805 tonnes, with revenue down 18% to GBP58.8 million, reflecting mix as a key driver.

On a year-to-date basis, Victrex sales volume of 2,797 tonnes was broadly in line with the prior year's 2,811 tonnes. Year-to-date revenue stands at GBP210.3 million, down 3% compared to GBP217.8 million a year prior.

Looking ahead, Victrex said with lower production levels and a weak product mix will hurt margins in the second half and in financial 2021.

Elsewhere, boohoo said it is launching an immediate independent review of its UK supply chain, led by Alison Levitt QC. The fashion retailer said it is also accelerating its independent third party supply chain review with ethical audit and compliance specialists Verisio and Bureau Veritas.

In addition, boohoo said it will be making an initial commitment to invest an incremental GBP10 million to eradicate supply chain malpractice.

The move comes after Next and ASOS have dropped boohoo clothing from their websites after claims that the fast-fashion retailer sold clothes made in factories where staff were paid less than the minimum wage and worked in poor conditions.

boohoo has had more than GBP1 billion wiped from its share value in the past two days after an article in the Sunday Times newspaper alleged that workers in a Leicester factory making clothes destined for boohoo were being paid as little as GBP3.50 an hour.

In New York on Tuesday, the Dow Jones Industrial Average ended down 1.5%, the S&P 500 down 1.1%, and the Nasdaq Composite down 0.9%.

US President Donald Trump has formally started the withdrawal of the US from the World Health Organization, making good on threats over the UN body's response to the coronavirus, officials said Tuesday.

The US is the largest financial contributor to the WHO – which leads the fight on global maladies from polio to measles to mental health – but it has increasingly been in Trump's crosshairs as the coronavirus takes a heavy toll.

After threatening to suspend the USD400 million in annual US contributions and then announcing a withdrawal, Trump has formally informed UN Secretary-General Antonio Guterres that he has started the US pullout, a State Department spokesperson said.

The withdrawal is effective in one year – July 6, 2021 – and Joe Biden, Trump's presumptive Democratic opponent, is virtually certain to stop it and stay in the WHO if he defeats Trump in the November election.

The US, the country hardest hit by the coronavirus, on Tuesday posted 60,209 new cases, a record for a 24-hour period, according to a tally from Johns Hopkins University.

In Asia on Wednesday, Nikkei 225 index in Tokyo closed down 0.8%. In China, the Shanghai Composite is up 1.8%, while the Hang Seng index in Hong Kong is up 0.3%.

China opened a new office on Wednesday for its intelligence agents to operate openly in Hong Kong for the first time under a tough new security law, in a public display of its tightening control over the finance hub.

The new base is located in a rapidly-converted hotel overlooking the city's Victoria Park, a location that has hosted pro-democracy protests for years, including an annual vigil marking Beijing's deadly Tiananmen crackdown.

Against the yen, the dollar was quoted at JPY107.55, broadly flat from JPY107.52 at the close on Tuesday.

The euro traded at USD1.1274 early Wednesday, down from USD1.1297 late Tuesday.

Sterling was quoted at USD1.2552 early Wednesday, softer than USD1.2586 at the London equities close on Tuesday.

Gold was priced at USD1,794.40 an ounce early Wednesday, higher than USD1,793.61 on Tuesday. Brent oil was trading at USD42.86 a barrel, lower than USD43.26.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
Today 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.